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A B S T R A C T
Introduction: Human parvovirus B19 is a DNA virus most known for causing erythema infectiosum in
children, and polyarthropathy or transient aplastic crisis in adults. However, various unusual clinical
manifestations have also been reported in association with it. We describe a young patient who
presented with splenic infarcts as a rare complication of B19 infection.
Case report: A 33-year old previously healthy man was admitted to our hospital because of a 5-day
history of fever and headache. Imaging studies revaled two splenic infarcts. Endocarditis was ruled out,
whereas serologic testing for B19 was indicative of acute infection.
Discussion: To our knowledge, three cases of thromboembolism in the setting of B19 infection have been
reported up to now, including one occurence of splenic infarction. These events were attributed to the
development of a transient antiphospholipid antibody syndrome. In contrast, our patient did not have
elevated titers of antiphospholipid antibodies.
Conclusions: Splenic infarcts can be an atypical presentation of B19 infection. Parvovirus B19 may induce
thromboembolic events, even in the absence of antiphospholipid antibodies.
 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Human parvovirus B19 is most known for causing erythema
infectiosum in children, transient red cell aplasia which can be
signiﬁcant in those with hemolytic anemia or polyarthropathy in
adults [1,2].
Case report
A 33-year old man was admitted to our hospital because of a
5-day history of continuous fever up to 39 8C, and diffuse headache.
He was unmarried and lived with his parents in Thirasia Island
near Santorini, working as a builder, was sexually active and
consistently used condoms. He did not smoke, use illicit drugs, or
misuse alcohol, had no pets or exposures to animals, and had never
traveled abroad. The man reported no recent tick or mosquito
bites, no ingestion of unpasteurized milk or milk products, and no
sick contacts and had received all routine childhood vaccinations,
had no known medical problems, and did not take any medica-
tions. His family history was negative for tuberculosis, cancer or
autoimmune disease.* Corresponding author. Tel.: +30 6974071547.
E-mail address: gekranid@hotmail.com (G. Kranidiotis).
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4.0/).On physical examination, the patient appeared well and was in
no acute distress; he was alert and communicative. His tempera-
ture was 39 8C, heart rate 73 beats per minute, blood pressure 120/
80 mmHg, respiratory rate 16 breaths per minute, and oxygen
saturation 99% while breathing ambient air. He had no synovitis,
rash, photophobia, or nuchal rigidity. His abdomen was soft, with
mild tenderness in the left upper quadrant on deep palpation.
There was no hepatomegaly or splenomegaly, and no cervical,
axillary, or femoral lymphadenopathy. Heart murmurs were not
detected.
Laboratory analyses revealed normocytic, normochromic ane-
mia (hemoglobin level, 12 g per deciliter), with a low reticulocyte
count (0.3%), leukopenia (white-cell count, 3420 per cubic
millimeter, with 68% neutrophils, 25% lymphocytes, 7% monocytes,
and no eosinophils or band forms), thrombocytopenia (platelet
count, 87,000 per cubic millimeter), and elevated levels of hepatic
aminotransferases (aspartate transaminase 138 U per liter, alanine
transaminase 111 U per liter), lactate dehydrogenase (1383 U per
liter), creatine phosphokinase (1019 U per liter), and C-reactive
protein (112 mg per liter). Clotting times (dilute prothrombin time
and activated partial-thromboplastin time) were not prolonged.
Urinalysis was normal. Multiple blood cultures were sterile.
An abdominal ultrasound examination revealed a mildly
enlarged spleen, with two peripheral wedge-shaped hypoechoic
lesions, which were characteristic of splenic infarcts. A computede under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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administration of intravenous and oral contrast material, con-
ﬁrmed the results of ultrasonography, demonstrating splenomeg-
aly (with the spleen measuring 15.4 cm in the craniocaudal
dimension), and two wedge-shaped areas of hypoenhancement in
the periphery of the spleen, features that were consistent with
splenic infarcts. No other organ abnormality was observed. An
electrocardiogram showed sinus rhythm. Transesophageal echo-
cardiography showed no valvular vegetations.
Hepatitis A immunoglobulin M (IgM) antibody, hepatitis B
surface antigen and core IgM antibody, a polymerase chain
reaction (PCR) assay for hepatitis C viral RNA, and serologic tests
for cytomegalovirus (CMV), herpes simplex virus, coxsackie A
virus, echovirus, human immunodeﬁciency virus, Rickettsia species,
Coxiella burnetii, Brucella melitensis, and Leishmania were negative,
as was real-time reverse transcriptase PCR for H1N1 inﬂuenza A
virus. Antibody tests for Epstein–Barr virus (EBV), coxsackie B
virus, and Toxoplasma gondii showed evidence of past infection.
Parvovirus B19 IgM antibodies were positive, while parvovirus B19
immunoglobulin G (IgG) antibodies were negative, indicating an
acute infection. Titers of anticardiolipin and anti-b2-glycoprotein I
antibodies were within normal limits. The patient received
symptomatic treatment with antipyretic and analgesic agents.
Over the following few days, his clinical and laboratory status
gradually improved. On the ﬁfth hospital day, his fever resolved. He
was discharged home on the tenth hospital day. Whether he
developed parvovirus B19-speciﬁc IgG antibodies during the
convalescent phase remained unknown, because the relevant test
could not be performed in his island.
Discussion
Splenic infarction occurs as a result of the occlusion of the
splenic artery or its branches due to thrombosis or embolism
[3]. The most common etiologies are hematologic diseases,
including myeloid disorders, lymphomas, hemoglobinopathies,
and hypercoagulable states; cardioembolic events; viral infec-
tions; and trauma [4,5]. The majority of patients present with pain
in the left upper quadrant or left ﬂank or both. However, as in this
case, a surprising percentage of patients have no symptoms
localized to the splenic area. The most frequent laboratory
abnormality is elevated lactate dehydrogenase levels, as seen in
our patient [6].
A major concern, when evaluating a patient with fever
accompanied by splenomegaly and splenic infarcts, is bacterialFig. 1. Abdominal computed tomography scan with intravenous and oral contrast
(venous phase): two wedge-shaped areas of hypoenhancement, consistent with
splenic infarcts, are present in the periphery of the spleen.endocarditis. This diagnosis was ruled out by sterile blood cultures
and normal transesophageal echocardiography as well as recovery
without antimicrobials. Additionally, the acuity of our patient’s
illness, and his rapid and complete recovery argued against
hematologic malignancies, being most consistent with a viral
infection. The viral infections that have been associated with
splenic infarcts are infectious mononucleosis [7,8] and acute CMV
infection [9]. Both conditions were excluded on the basis of
negative serologic testing.
Our patient did not present with any of the classic syndromes
associated with PVB19 infection. Nevertheless, he had a remark-
ably low reticulocyte count. Asymptomatic transient reticulocy-
topenia is a hallmark laboratory feature of PVB19 infection. PVB19
replicates primarily in erythroid progenitors. Virus-induced
cytotoxicity results in cessation of red cell production. In
individuals without hemolytic anemia, this transient arrest of
red cell production will lead to only a minimal drop in hemoglobin
levels but in patients with increased destruction of red cells, who
depend on continual rapid production of erythrocytes (hemoglo-
binopathies or hemolytic anemias), this suppression of erythro-
poiesis can cause a transient aplastic crisis with severe anemia
[1,10].
A wide range of unusual clinical manifestations have been
reported in association with PVB19 infection, including vasculitis,
myocarditis, glomerulonephritis, peripheral neuropathy, meningi-
tis and encephalitis, immune thrombocytopenia, and hemopha-
gocytic syndrome [11]. Three cases of thromboembolism have also
been described, to our knowledge; a man with a splenic infarct
[12], a woman with multiple pulmonary emboli [13], and a woman
with right pulmonary arterial and superior mesenteric venous
thromboses [14]. Similar to our case, all these occurrences involved
young previously healthy patients who recovered fully. In regards
to pathogenesis, they were attributed to the development of a
transient antiphospholipid antibody syndrome. Our patient did not
have elevated titers of antiphospholipid antibodies. Consequently,
other unknown mechanisms also account for the thromboembolic
phenomena observed in the setting of PVB19 infection.
Conclusions
Splenic infarcts may be an atypical presentation of PVB19
infection. PVB19 infection should be considered in the differential
diagnosis of fever accompanied by splenic infarcts in immuno-
competent young adults. Clinicians must be aware of PVB19
propensity to induce thromboembolic events, regardless of the
presence of antiphospholipid antibodies.
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